NCT01452477

Tanshinone in Polycystic Ovary Syndrome

Effect of Tanshinone on Hormonal and Metabolic Features in Women With Polycystic Ovary Syndrome (PCOS)

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Heilongjiang University of Chinese Medicine · Academic / Other
• Sex: Female
• Age: 18 Years – 36 Years
• Healthy volunteers: Not accepted

Summary

Tanshinone was originally isolated from dried roots of Salvia miltiorrhiza bunge. In Chinese medicine, this herb has been widely prescribed for several pathologies, including diabetes, acne, cardiovascular disease.It has been demonstrated that the therapeutic benefit of cryptotanshinone on prenatally androgenized rats may be mediated by its dual regulation of key molecules during both insulin signaling and androgen synthesis.The purpose of this study is to determine whether tanshinone may prove effective in eradicating Polycystic Ovary Syndrome (PCOS) symptomatology.

Conditions

• Polycystic Ovary Syndrome

Interventions

Type	Name	Description
DRUG	tanshinone	tanshinone 1.0g / time, 3 times / day orally, continuous treatment for 12 weeks.
DRUG	tanshinone placebo	placebo 1.0g / time, 3 times / day orally, continuous treatment for 12 weeks.

Timeline

• Start date: 2011-10-01
• Primary completion: 2013-12-01
• Completion: 2014-07-01
• First posted: 2011-10-14
• Last updated: 2013-09-04

Locations

4 sites across 1 country: China